Sarepta Therapeutics, Inc.

Rachunek Zysków i Strat


Statystyki
Dywidendy
Rekomendacje
Wyceny
Wskaźniki
Analiza techniczna



Przychody TTM (mln): 1 505
EBIT TTM (mln): 23
index 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24
Rok finansowy 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Przychód (mln) 1 1 1 1 0 5 0 11 21 18 29 47 37 14 10 1 5 155 301 381 540 702 933 1,243 1,902
Przychód Δ r/r 0.0% -45.6% 18.5% 15.9% -55.6% 1011.3% -97.6% 9428.2% 93.5% -17.3% 67.3% 59.7% -20.6% -61.9% -31.4% -87.2% 332.6% 2751.6% 94.7% 26.5% 41.8% 30.0% 32.9% 33.3% 53.0%
Marża brutto 132.1% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 6.7% 23.5% -39.1% -408.6% -864.5% -11567.5% -3332.2% 95.2% -44.8% 84.9% 83.3% 80.8% 80.5% 84.3% 83.2%
EBIT (mln) -10 -15 -25 -19 -25 -18 -33 -33 -27 -16 -21 -36 -29 -90 -134 -211 -262 -143 -344 -522 -564 -449 -530 -268 218
EBIT Δ r/r 0.0% 50.4% 64.5% -25.5% 32.7% -30.1% 88.3% 0.4% -17.1% -43.5% 35.0% 71.6% -19.0% 208.0% 49.0% 57.7% 24.2% -45.5% 140.9% 52.0% 8.0% -20.4% 18.0% -49.5% -181.4%
EBIT (%) -789.4% -2181.4% -3028.4% -1946.0% -5817.9% -366.2% -28608.5% -301.4% -129.2% -88.2% -71.2% -76.5% -78.0% -630.8% -1369.9% -16823.8% -4830.6% -92.3% -114.1% -137.1% -104.4% -64.0% -56.8% -21.5% 11.5%
Koszty finansowe (mln) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 31 60 64 53 22 18
EBITDA (mln) -10 -15 -24 -17 -23 -15 -29 -25 -22 -14 -19 -35 -28 -88 -130 -206 -256 -135 -332 -492 -524 -400 -476 -209 317
EBITDA(%) -757.3% -329.0% -2333.9% -2181.2% -5379.3% -324.4% -26795.4% -328.2% -43.8% -28.0% -27.1% -146.7% -73.9% -621.8% -1332.1% -16405.0% -4727.1% -87.1% -110.2% -129.1% -97.1% -57.0% -51.0% -16.8% 16.7%
Podatek (mln) 0 12 4 -4 0 0 0 -6 6 10 11 -35 0 0 0 0 0 2 1 1 1 -0 14 16 26
Zysk Netto (mln) -9 -27 -29 -15 -25 -17 -31 -27 -24 -25 -32 -2 -121 -112 -136 -220 -267 -51 -362 -715 -554 -419 -703 -536 235
Zysk netto Δ r/r 0.0% 191.4% 9.0% -50.2% 69.5% -32.7% 86.3% -12.6% -11.8% 5.0% 27.9% -92.8% 5132.4% -7.7% 21.3% 62.0% 21.5% -81.0% 614.0% 97.6% -22.5% -24.4% 68.0% -23.8% -143.9%
Zysk netto (%) -712.2% -3813.2% -3508.6% -1507.1% -5756.1% -348.6% -26951.8% -247.3% -112.7% -143.1% -109.4% -4.9% -324.9% -787.6% -1391.7% -17560.3% -4930.2% -32.8% -120.2% -187.8% -102.6% -59.7% -75.4% -43.1% 12.4%
EPS -2.96 -7.21 -6.86 -2.94 -4.13 -2.24 -3.54 -3.02 -2.07 -1.62 -1.74 -0.11 -5.14 -3.31 -3.39 -5.2 -5.49 -0.86 -5.46 -9.71 -7.11 -5.15 -8.03 -5.8 2.47
EPS (rozwodnione) -2.96 -7.21 -6.86 -2.94 -4.13 -2.24 -3.54 -3.02 -2.07 -1.62 -1.74 -0.11 -5.14 -3.31 -3.39 -5.2 -5.49 -0.86 -5.46 -9.71 -7.11 -5.15 -8.03 -5.8 2.18
Ilośc akcji (mln) 3 4 4 5 6 7 9 9 12 16 19 22 24 34 40 42 49 59 66 74 78 81 88 92 95
Ważona ilośc akcji (mln) 3 4 4 5 6 7 9 9 12 16 19 22 24 34 40 42 49 59 66 74 78 81 88 92 108
Waluta USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD